Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Benekli

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Oncology|October 19, 2012
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancerNedim Turan, Mustafa Benekli, Dogan Koca, et al.
Onkologie|October 11, 2013
Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumabOnder Tonyali, Ugur Coskun, Nur Sener, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 25, 2015
Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO)Olcun Umit Unal, Ilhan Oztop, Serkan Menekse, et al.
Hepato-Gastroenterology|November 21, 2012
Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experienceUmut Kefeli, Suleyman Buyuberber, Murat Akyol, et al.
Hepato-Gastroenterology|March 6, 2012
Adjuvant chemoradiation for gastric cancer: multicentric study of the Anatolian Society of Medical OncologyMehmet Kucukoner, Abdurrahman Isikdogan, Erkan Arpaci, et al.
Breast (Edinburgh, Scotland)|January 24, 2016
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumabOnder Tonyali, Ugur Coskun, Sinemis Yuksel, et al.
Contemporary Oncology (Poznan, Poland)|September 27, 2014
Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical OncologyKucukoner Mehmet, Cihan Sener, Ummugul Uyeturk, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2013
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Umut Demirci, Gulnihal Tufan, Bilge Aktas, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 22, 2012
Clinicopathological features in bilateral breast cancerMeltem Baykara, Selcuk Cemil Ozturk, Suleyman Buyukberber, et al.
Hepato-Gastroenterology|November 21, 2012
Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from TurkeyMesut Seker, Alper Sevinc, Ramazan Yildiz, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Oncology|October 19, 2012
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancerNedim Turan, Mustafa Benekli, Dogan Koca, et al.
Onkologie|October 11, 2013
Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumabOnder Tonyali, Ugur Coskun, Nur Sener, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 25, 2015
Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO)Olcun Umit Unal, Ilhan Oztop, Serkan Menekse, et al.
Hepato-Gastroenterology|November 21, 2012
Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experienceUmut Kefeli, Suleyman Buyuberber, Murat Akyol, et al.
Hepato-Gastroenterology|March 6, 2012
Adjuvant chemoradiation for gastric cancer: multicentric study of the Anatolian Society of Medical OncologyMehmet Kucukoner, Abdurrahman Isikdogan, Erkan Arpaci, et al.
Breast (Edinburgh, Scotland)|January 24, 2016
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumabOnder Tonyali, Ugur Coskun, Sinemis Yuksel, et al.
Contemporary Oncology (Poznan, Poland)|September 27, 2014
Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical OncologyKucukoner Mehmet, Cihan Sener, Ummugul Uyeturk, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2013
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Umut Demirci, Gulnihal Tufan, Bilge Aktas, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 22, 2012
Clinicopathological features in bilateral breast cancerMeltem Baykara, Selcuk Cemil Ozturk, Suleyman Buyukberber, et al.
Hepato-Gastroenterology|November 21, 2012
Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from TurkeyMesut Seker, Alper Sevinc, Ramazan Yildiz, et al.
Pageof 13